People with more than one tattoo session may have a decreased risk of developing melanoma—with one key caveat, according to a study evaluating over 7,000 individuals.
Just a handful of years ago, malignant melanoma was a diagnosis with few treatment options. Oncologists had no obvious roadmap for this perilous disease and were forced to explore beyond targeted therapies and chemotherapy.
When combined with nivolumab, RP1 induced systemic responses in patients with advanced melanoma who have failed to respond to prior anti–PD-1 therapy, according to findings from the phase I/II IGNYTE ...
Scratching an itch may have positive and negative outcomes. Compounds in tomatoes may work as an antidepressant. Selenoproteins help keep blood young. And more.